TARO
Taro Pharmaceutical Industries

260
Loading...
Loading...
News
all
press releases
TARO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Taro Pharmaceutical Industries Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Taro Pharmaceutical Industries Ltd...
Business Wire·1y ago
News Placeholder
More News
News Placeholder
TARO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Taro Pharmaceutical Industries Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
TARO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Taro Pharmaceutical Industries Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! TARO...
PR Newswire·1y ago
News Placeholder
TARO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Taro Pharmaceutical Industries Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Taro Pharmaceutical Industries Ltd...
Business Wire·1y ago
News Placeholder
TARO Investors Have Opportunity to Lead Taro Pharmaceutical Industries Ltd. Securities Fraud Lawsuit with the Schall Law Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Taro Pharmaceutical Industries Ltd. (Taro or the Company) (NYSE: TARO) for...
Business Wire·1y ago
News Placeholder
TARO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Taro Pharmaceutical Industries Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
TARO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Taro Pharmaceutical Industries Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! TARO...
PR Newswire·1y ago
News Placeholder
Ademi LLP announces the filing of Class Action Lawsuit against Taro Pharmaceutical Industries Ltd. and other Defendants
Ademi LLP announces the filing of Class Action Lawsuit against Taro Pharmaceutical Industries Ltd. and other Defendants Ademi LLP announces the filing of Class Action Lawsuit against Taro...
PR Newswire·1y ago
News Placeholder
Sun Pharma Completes Taro Merger
Sun Pharma Completes Taro Merger Sun Pharma Completes Taro Merger PR Newswire MUMBAI, India and PRINCETON, N.J., June 24, 2024 Combined entity is better positioned to compete in increasingly...
PR Newswire·1y ago
News Placeholder
Taro Shareholders Approve Merger with Sun Pharma
Taro Shareholders Approve Merger with Sun Pharma Taro Shareholders Approve Merger with Sun Pharma PR Newswire MUMBAI, India and NEW YORK, May 23, 2024 MUMBAI, India and NEW YORK, May 23, 2024...
PR Newswire·1y ago
News Placeholder
Taro Provides Results for Year Ended March 31, 2024
Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (Taro or the Company) today provided unaudited financial results for the quarter and year ended March 31, 2024. Quarter ended March 31, 2024...
Business Wire·1y ago
News Placeholder
Shareholder Alert: Ademi LLP investigates whether Taro Pharmaceutical Industries Limited has obtained a Fair Price for its Public Shareholders in its transaction with its majority shareholder, Sun Pharmaceutical Industries Limited.
Shareholder Alert: Ademi LLP investigates whether Taro Pharmaceutical Industries Limited has obtained a Fair Price for its Public Shareholders in its transaction with its majority shareholder, Sun...
PR Newswire·1y ago

Latest TARO News

View

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.